Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,692
datasets available to search
ShareScore release 0.9.0
Dataset results
2,692 results for “Medicine”
Dataset of "A multi-method approach to drafting candidate entrustable professional activities for a general internal medicine residency programme"
<p>The present Dataset is related to a study on "A multi-method approach to drafting candidate entrustable professional activities for a general internal medicine residency programme" and include :</p> <ul> <li>The "Voting sheet model" used for the 1st round of voting according to the RAND appropriateness method</li> <li>The tables of aggregate results after round 1 and after round 2 of the RAND appropriateness method, with subgroup analysis</li> <li>A document describing which items where chosen to be included in round 2 of voting and why (file name "Summary_Decisions_.....")</li> <li>The list of candidate EPA (Entrustable Professional Activities) selected after 2 round of rating by the expert panel. This list of 225 EPA had not yet undergone the quality check using the EQual-Criteria (DOI: 10.1097/ACM.0000000000001908)</li> </ul> <p><strong><u><span>Methods:</span></u></strong><span> We set up a multi-step approach including a systematic review of the international literature; four national focus groups; a national consensus process using a RAND appropriateness method and a quality check of the </span><u><span>selected candidate EPAs using Equal criteria.</span></u></p> <p><strong><u><span>Results:</span></u></strong><span> </span><span>These steps generated a final list of 247 candidate EPAs in GIM </span><span>that were submitted for the national consensus process. A</span><span>fter two rounds of rating, experts agreed on the appropriateness for the GIM postgraduate training of 225 of the candidate EPAs. Twenty-two of the proposed EPAs were deemed inappropriate and disagreement persisted only for two EPAs.</span><span> </span></p> <p> </p> <p><strong>General description of the data set :</strong></p> <p>o Nature: aggregated, analysed data</p> <p>o Mode of collection: experimental</p> <p>o Format: unstructured text, database</p> <p> </p>
Traditional medicinal use is linked with apparency, not specialized metabolite profiles in the order Caryophyllales
<p>A better understanding of the relationship between plant specialized metabolism and traditional medicine has the potential to aid in bioprospecting and untangling of cross-cultural use patterns. However, given the limited information available for metabolites in most plant species, understanding medicinal use-metabolite relationships can be difficult. The order Caryophyllales has a unique pattern of lineages of tyrosine- or phenylalanine-dominated specialized metabolism, represented by mutually exclusive anthocyanin and betalain pigments, making Caryophyllales a compelling system to explore the relationship between medicine and metabolites by using pigment as a proxy for tyrosine- vs phenylalanine-dominant metabolism. We compiled a list of medicinal species in select tyrosine- or phenylalanine-dominant families of Caryophyllales (Nepenthaceae, Polygonaceae, Simmondsiaceae, Microteaceae, Caryophyllaceae, Amaranthaceae, Limeaceae, Molluginaceae, Portulacaceae, Cactaceae, and Nyctaginaceae) by searching scientific literature until no new medicinal uses were recovered. We then tested for phylogenetic clustering of uses using a "hot nodes" approach. To test potential non-metabolite drivers of medicinal use, like how often humans encounter a species (apparency), we repeated the analysis using only North American species across the entire order and performed phylogenetic generalized least squares regression (PGLS) with occurrence data from the Global Biodiversity Information Facility (GBIF). We hypothesized families with tyrosine-enriched metabolism would show clustering of different types of medicinal use compared to phenylalanine-enriched metabolism. Instead, wide-ranging, apparent clades in Polygonaceae and Amaranthaceae are overrepresented across nearly all types of medicinal use. Our results suggest that apparency is a better predictor of medicinal use than metabolite profile, although metabolism type may still be a contributing factor.</p>
DREAMING - Diminished Reality for Emerging Applications in Medicine through Inpainting Dataset
<p>Dataset for the <strong>DREAMING - Diminished Reality for Emerging Applications in Medicine through Inpainting Challenge</strong></p> <p>More information about the challenge and challenge registration can be found on the <a href="https://dreaming.grand-challenge.org/" target="_blank" rel="noopener">challenge platform</a>!</p> <p> </p> <p><em><strong>Timeline:</strong></em></p> <p><strong>8th January 2024: </strong>First subset of training & validation data available (scenes 0000-0009).</p> <p><strong>22nd January 2024:</strong> Second subset of training & validation data available (scenes 0010-0049).</p> <p><strong>26th January 2024:</strong> Full training & validation data available (scenes 0050-0100).</p> <p> </p> <p><strong>Description:</strong></p> <p>The dataset was created using <a href="https://www.unrealengine.com">Unreal Engine 5.1</a>, <a href="https://www.unrealengine.com/en-US/metahuman">Unreal MetaHumans</a>, <a href="../records/10091715" target="_blank" rel="noopener">3D-COSI surgical instruments</a>, <a href="https://github.com/BatFaceWayne/POV_Surgery" target="_blank" rel="noopener">POV-Surgery grasp generation</a> and <a href="https://github.com/ydrive/EasySynth" target="_blank" rel="noopener">EasySynth</a>.</p> <p>Each scene contains:</p> <ul> <li>"color": RGB input images</li> <li>"gt": RGB ground truth images</li> <li>"mask": Mask defining the area to be inpainted. White -> Background, Black -> Inpainting area</li> <li>"CameraPoses.csv": Camera poses</li> <li>"CameraRig.json": Camera intrinsics</li> </ul> <p>To cite the dataset, please use</p> <pre><code>@online{gsaxner_2024_10570773, author = {Gsaxner, Christina and van Meegdenburg, Timo and Luijten, Gijs and Vu, Viet Duc and Puladi, Behrus and Egger, Jan}, title = {{DREAMING - Diminished Reality for Emerging Applications in Medicine through Inpainting Dataset}}, month = jan, year = 2024, publisher = {Zenodo}, doi = {10.5281/zenodo.10570773}, url = {https://doi.org/10.5281/zenodo.10570773} }</code></pre> <p> </p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Croatia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Croatia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Croatian Food Agency</p> <p>VMPR_2022 – Croatian Food Agency</p> <p>VMPR_2021 – Croatian Food Agency</p> <p>VMPR_2020 – Croatian Food Agency</p> <p>VMPR_2019 – Croatian Food Agency</p> <p>VMPR_2018 – Croatian Food Agency</p> <p>VMPR_2017 – Croatian Food Agency</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Ireland
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Ireland. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2022 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2021 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2020 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2019 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2018 – Department of Agriculture, Food and the Marine</p> <p>VMPR_2017 – Department of Agriculture, Food and the Marine</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Finland
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Finland. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Finnish Food Authority</p> <p>VMPR_2022 – Finnish Food Authority</p> <p>VMPR_2021 – Finnish Food Authority</p> <p>VMPR_2020 – Finnish Food Authority</p> <p>VMPR_2019 – Finnish Food Authority</p> <p>VMPR_2018 – Finnish Food Authority</p> <p>VMPR_2017 – Finnish Food Authority</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Greece
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Greece. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Ministry of Rural Development and Food</p> <p>VMPR_2022 – Ministry of Rural Development and Food</p> <p>VMPR_2021 – Ministry of Rural Development and Food</p> <p>VMPR_2020 – Ministry of Rural Development and Food</p> <p>VMPR_2019 – Ministry of Rural Development and Food</p> <p>VMPR_2018 – Ministry of Rural Development and Food</p> <p>VMPR_2017 – Ministry of Rural Development and Food</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Luxembourg
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Luxembourg. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Veterinary Service Administration</p> <p>VMPR_2022 – Veterinary Service Administration</p> <p>VMPR_2021 – Veterinary Service Administration</p> <p>VMPR_2020 – Veterinary Service Administration</p> <p>VMPR_2019 – Veterinary Service Administration</p> <p>VMPR_2018 – Veterinary Service Administration</p> <p>VMPR_2017 – Veterinary Service Administration</p> <p> </p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Cyprus
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Cyprus. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – State General Laboratory - Ministry of Health</p> <p>VMPR_2022 – State General Laboratory - Ministry of Health</p> <p>VMPR_2021 – State General Laboratory - Ministry of Health</p> <p>VMPR_2020 – State General Laboratory - Ministry of Health</p> <p>VMPR_2019 – State General Laboratory - Ministry of Health</p> <p>VMPR_2018 – State General Laboratory - Ministry of Health</p> <p>VMPR_2017 – State General Laboratory - Ministry of Health</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Latvia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Latvia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2022 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2021 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2020 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2019 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2018 – Institute of Food Safety, Animal Health and Environment</p> <p>VMPR_2017 – Institute of Food Safety, Animal Health and Environment</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Slovakia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Slovakia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2022 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2021 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2020 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2019 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2018 – State Veterinary and Food Administration of the Slovak Republic</p> <p>VMPR_2017 – State Veterinary and Food Administration of the Slovak Republic</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - The Netherlands
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of The Netherlands. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Netherlands Food and Consumer Product Safety Authority</p> <p>VMPR_2022 – Netherlands Food and Consumer Product Safety Authority</p> <p>VMPR_2021 – Netherlands Food and Consumer Product Safety Authority</p> <p>VMPR_2020 – National Institute for Public Health and the Environment</p> <p>VMPR_2019 – National Institute for Public Health and the Environment </p> <p>VMPR_2018 – National Institute for Public Health and the Environment</p> <p>VMPR_2017 – National Institute for Public Health and the Environment</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Malta
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Malta. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Ministry for Agriculture, Fisheries and Animal Rights</p> <p>VMPR_2022 – Ministry for Agriculture, Fisheries and Animal Rights</p> <p>VMPR_2021 – Ministry for Agriculture, Fisheries and Animal Rights</p> <p>VMPR_2020 – Ministry for Agriculture, Fisheries and Animal Rights</p> <p>VMPR_2018 – Ministry for the Environment, Sustainable Development and Climate Change</p> <p>VMPR_2017 – Ministry for the Environment, Sustainable Development and Climate Change</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Serbia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Serbia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The chemical monitoring data collected and published by EFSA include the analytical results provided by EU Member States and three pre-accession countries: Bosnia-Herzegovina, Montenegro, North Macedonia and Serbia.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Institute of Meat Hygiene and Technology</p> <p>VMPR_2022 – Institute of Meat Hygiene and Technology</p> <p>VMPR_2021 – Institute of Meat Hygiene and Technology</p> <p>VMPR_2020 – Institute of Meat Hygiene and Technology</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Portugal
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Portugal. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Directorate-General for Food and Veterinary</p> <p>VMPR_2022 – Directorate-General for Food and Veterinary; National Institute of Health Dr. Ricardo Jorge</p> <p>VMPR_2021 – Directorate-General for Food and Veterinary; National Institute of Health Dr. Ricardo Jorge</p> <p>VMPR_2020 – Directorate-General for Food and Veterinary; National Institute of Health Dr. Ricardo Jorge</p> <p>VMPR_2019 – Directorate-General for Food and Veterinary; National Institute of Health Dr. Ricardo Jorge</p> <p>VMPR_2018 – Directorate-General for Food and Veterinary; National Institute of Health Dr. Ricardo Jorge</p> <p>VMPR_2017 – Directorate-General for Food and Veterinary</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Italy
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Italy. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Ministry of Health</p> <p>VMPR_2022 – Ministry of Health</p> <p>VMPR_2021 – Ministry of Health</p> <p>VMPR_2020 – Ministry of Health</p> <p>VMPR_2019 – Ministry of Health</p> <p>VMPR_2018 – Ministry of Health</p> <p>VMPR_2017 – Ministry of Health</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - North Macedonia
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of North Macedonia. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The chemical monitoring data collected and published by EFSA include the analytical results provided by EU Member States and three pre-accession countries: Bosnia-Herzegovina, Montenegro, North Macedonia and Serbia.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Food and Veterinary Agency</p> <p>VMPR_2022 – Food and Veterinary Agency</p> <p>VMPR_2021 – Food and Veterinary Agency</p> <p>VMPR_2020 – Faculty of Veterinary Medicine - Skopje</p> <p>VMPR_2019 – Faculty of Veterinary Medicine - Skopje</p> <p>VMPR_2018 – Food and Veterinary Agency</p> <p>VMPR_2017 – Food and Veterinary Agency</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Iceland
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Iceland. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p><br>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p><br>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p><br>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p><br>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p><br>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p><br>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p><br>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p><br>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Icelandic Food and Veterinary Authority</p> <p>VMPR_2022 – Icelandic Food and Veterinary Authority</p> <p>VMPR_2021 – Icelandic Food and Veterinary Authority</p> <p>VMPR_2020 – Icelandic Food and Veterinary Authority</p> <p>VMPR_2019 – Icelandic Food and Veterinary Authority</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Norway
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Norway. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Norwegian Food Safety Authority; Institute of Marine Research</p> <p>VMPR_2022 – Norwegian Food Safety Authority; Institute of Marine Research</p> <p>VMPR_2021 – Norwegian Food Safety Authority; Institute of Marine Research</p> <p>VMPR_2020 – Norwegian Food Safety Authority</p> <p>VMPR_2019 – Norwegian Food Safety Authority</p>
Results from the monitoring of veterinary medicinal product residues and other substances in live animals and animal products - Austria
<p>This dataset contains the monitoring results of veterinary medicinal product residues and other substances measured in live animals and animal products analysed by the national competent authority of Austria. The presence of unauthorised substances, residues of veterinary medicinal products in food may pose a risk factor for public health.</p> <p>For this reason and in order to ensure a high level of consumer protection, a comprehensive legislative framework has been established in the European Union (EU) which defines maximum limits permitted in food and monitoring programmes for the control of the presence of these substances in the food chain. Regulation (EU) No 37/2010 establishes maximum limits for residues of veterinary medicinal products in food-producing animals and animal products. Maximum residue levels for pesticides in or on food and feed of plant and animal origin are laid down in Regulation (EC) No 396/2005. Commission Implementing Regulation (EU) 2022/1646 lays down practical arrangements for and specific content of official controls of the use of veterinary medicinal products in live animals and products of animal origin through three different official national control plans: a national risk-based control plan for production in the Member States, a national randomised surveillance plan for production in the Member States and a national risk-based control plan for third-country imports. Additionally, Commission Delegated Regulation (EU) 2022/1644 lays down the range of samples and stage of production, processing and distribution at which the samples are to be taken.</p> <p>Since 2018 until 2022, the data on the national residue monitoring plan were reported to EFSA in accordance with Council Directive 96/23/EC.</p> <p>The dataset contains the results of laboratory tests from samples taken from bovines, pigs, sheep, goats, horses, poultry, rabbits, farmed game, wild game aquaculture, milk, eggs and honey, and from 2023 also samples from casings, insects and reptiles.</p> <p>Targeted samples are taken with the aim of detecting illegal treatment or controlling compliance with the maximum levels laid down in the relevant legislation. This means that, in their national plans Member States target the groups of animals (species, gender, age) where the probability of finding residues is the highest. Conversely, the objective of random sampling is to collect significant data to evaluate, for example, consumer exposure to a specific substance.</p> <p>Suspect samples are taken as a consequence of i) non-compliant results on samples taken in accordance with the control plans, ii) possession or presence of prohibited substances at any point during manufacture, storage, distribution or sale through the food and feed production chain, or iii) suspicion or evidence of illegal treatment or non-compliance with the withdrawal period for an authorised medicinal veterinary product.</p> <p>Residues of pharmacologically active substances mean active substances, excipients or degradation products and their metabolites, which remain in food.</p> <p>Unauthorised substances mean substances that are not authorised as veterinary medicinal products or as a feed additive under European Union legislation.</p> <p>Prohibited substances mean substances which are prohibited for use in food producing animals according to the European Union legislation.</p> <p>Non-compliant sample is a sample that has been analysed for the presence of one or more substances and failed to comply with the legal provisions for at least one substance. Thus, a sample can be non-compliant for one or more substances.</p> <p><strong>REPORTING AUTHORITIES CONTRIBUTING TO EACH DATA COLLECTION:</strong></p> <p>VMPR_2023 – Austrian Agency for Health and Food Safety</p> <p>VMPR_2022 – Austrian Agency for Health and Food Safety</p> <p>VMPR_2021 – Austrian Agency for Health and Food Safety</p> <p>VMPR_2020 – Austrian Agency for Health and Food Safety</p> <p>VMPR_2019 – Austrian Agency for Health and Food Safety</p> <p>VMPR_2018 – Austrian Agency for Health and Food Safety</p> <p>VMPR_2017 – Austrian Agency for Health and Food Safety</p>
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.